Mitesco (MITI) Research & Development (2011 - 2026)
Mitesco (MITI) reported Research & Development of $103533.0 for Q1 2026, up 1860.11% year-over-year from $5282.0 in Q1 2025, and up 74.02% on a QoQ basis from $59495.0 in Q4 2025.
Mitesco (MITI) has 7 years of Research & Development data on file, last reported at $103533.0 in Q1 2026.
- Quarterly Research & Development rose 1860.11% year-over-year to $103533.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $185250.0 (up 3407.19% YoY) and the FY2025 annual result came in at $81717.0, changed N/A from the prior year.
- Research & Development rose to $103533.0 in Q1 2026 per MITI's latest filing, from $59495.0 in the prior quarter.
- Across five years, Research & Development topped out at $103533.0 in Q1 2026 and bottomed at $1100.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 198.79 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 67.77 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 30.34 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 39.11 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 18.37 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 56.85 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 21.52 Mn |
| 10 | Mitesco | - | - | - | 103,533.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103,533.00 |
| Dec 31, 2025 | 59,495.00 |
| Sep 30, 2025 | 1,100.00 |
| Jun 30, 2025 | 21,122.00 |
| Sep 30, 2015 | 172,289.00 |
| Jun 30, 2015 | 172,289.00 |
| Mar 31, 2015 | 194,699.00 |
| Dec 31, 2014 | 225,875.00 |
| Sep 30, 2014 | 222,934.00 |
| Jun 30, 2014 | 222,934.00 |
| Mar 31, 2014 | 365,037.00 |
| Dec 31, 2013 | 244,946.00 |
| Sep 30, 2013 | 191,378.00 |
| Jun 30, 2013 | 483,426.00 |
| Mar 31, 2013 | 329,613.00 |
| Dec 31, 2012 | 167,032.00 |
| Sep 30, 2012 | 114,976.00 |
| Jun 30, 2012 | 273,985.00 |
| Mar 31, 2012 | 338,164.00 |
| Jun 30, 2011 | 296,321.00 |
| Mar 31, 2011 | 278,284.00 |